SELLAS Life Sciences Group, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | — | — | $0.0 | $1.0 | $7.6 |
| Operating income | -$28.3 | -$31.5 | -$37.9 | -$42.0 | -$25.3 |
| Net income | -$26.9 | -$30.9 | -$37.3 | -$41.3 | -$20.7 |
Shares outstanding 201.9M · Free float 98.2%
Annual filing data through FY ended December 31, 2025; float as of September 28, 2026.